AR19, a manipulation-resistant formulation of amphetamine sulfate, was created to address the problem of non-oral use of stimulant medications (eg, smoking, injecting). In this video, Dr Faraone highlights the findings and implications of a recent randomized controlled trial of AR19 in adult ADHD.
The Journal of Clinical Psychiatry
Insights August 24, 2021
AR19, a Manipulation-Resistant Formulation of Amphetamine Sulfate, in Adult ADHD
Vol 87 • 2026 • Number 2
Read the Current Issue
Original Research
CBT following Esketamine for Major Depression and Suicidal Ideation for Relapse Prevention: The CBT-ENDURE Randomized Trial
Original Research
Neuropsychiatric Symptom Clusters and Brain Structure in Alzheimer’s Disease
Systematic Review
Thirty Years of the Diagnostic Criteria for Psychosomatic Research
Original Research
Efficacy of Olanzapine/Samidorphan on Negative Symptoms
Original Research
Comparing Risk Prediction for Suicide Attempts and Deaths After Emergency Department Visits
Clinical and Practical Psychopharmacology
